Skip to content
DataLookout
Menu

CLEVERNCT05458323

Cognitive Level Enhancement Through Vision Exams and Refraction

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 17 versions: 16 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from Nov 30, 2027 to Nov 30, 2028 Show 7 more changesShow less
    • Eligibility criteria expanded, about 27 words
    • Enrollment closed, study ongoing
    • Enrollment target: estimated 820 to confirmed 821
    • Secondary endpoints revised (9)
    • Site details revised
    • Collaborators: 7 to 8
    • Publications: details revised at 1 of 1 entry
  2. Minor Study description expanded, about 18 wordsv16
  3. Minor Enrollment target: 760 to 820
    • Study description expanded, about 153 words
    • Publications: 55 to 1
    v15
  4. Minor Start date: Jan 19, 2024 to Jan 18, 2024
    • Study description expanded, about 110 words
    v14
  5. Notable Eligibility criteria shortened, about 25 words
    • Study description shortened, about 135 words
    v13
Show 10 earlier versionsHide 10 earlier versions
  1. Minor Study description expanded, about 100 wordsv12
  2. Minor Primary completion date: Jun 30, 2027 to Nov 30, 2027v11 Show 4 more changesShow less
    • Study completion date: Jan 31, 2028 to Dec 31, 2028
    • Secondary endpoints: details revised at 1 of 9 entries
    • Study description shortened, about 6 words
    • Publications: 54 to 55
  3. Notable Trial status: Not Yet Recruiting to Recruitingv10 Show 6 more changesShow less
    • Primary completion date: Aug 2025 to Jun 30, 2027
    • Eligibility criteria expanded, about 5 words
    • Study completion date: Sep 2026 to Jan 31, 2028
    • Start date changed from estimate of Jan 2024 to Jan 19, 2024
    • Study description expanded, about 27 words
    • Site details revised
  4. Notable Start date: Sep 2023 to Jan 2024v9
  5. Notable Start date: Jun 2023 to Sep 2023v8
  6. Notable Start date: Mar 2023 to Jun 2023v7
  7. Notable Start date: Dec 2022 to Mar 2023v5
  8. Notable Start date: Oct 2022 to Dec 2022v4
  9. Minor Start date: Sep 2022 to Oct 2022v3
  10. Notable Eligibility criteria expanded, about 14 wordsv2
  1. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Change in cognitive score
Timeframe: Time point(s) of primary interest: 36 months collected at 12, 24 and 36 months

Secondary (9)

26-Item Quality of Life
Cost effectiveness
Social interaction/isolation
Self-reported physical activity.
Falls risk
Show 4 moreShow less
Depression
Glasses compliance
Visual Function
Domain-specific cognitive function

Arms and interventions

Free near and distance glassesExperimental

All participants randomised to the intervention group will be provided with free near and/or distance spectacles based on the results of refraction. Glasses will be provided at the time of enrolment into the study. The participants will be asked to choose from an assortment of 20 frames. Participants will be asked to report to the study team member in case of any issue with spectacles or if spectacles are lost or broken. Replacement glasses will be provided in case of broken or lost spectacles whenever required. Participants will undergo annual eye exams and refraction, and change of glasses will be prescribed as needed.

Control-No treatmentNo intervention

All participants randomised to the control group will receive a prescription for spectacles and given free near and/or distance glasses as needed at study close out.

Devices: Free near and Distance Vision glasses

Sites

1 site in 1 country

  • L V Prasad Eye InstituteHyderabad, Telangana, India